Previous 10 | Next 10 |
MoneyShow.com news releases related Moneyshow.com news releases and Moneyshow.com press releases from 07/26/19 01:00:00 on US and Canada Markets.
Skilled management can be worth well than its expenses in any investment vehicle, asserts Brett Owens , fund specialist, income expert and editor of Contrarian Outlook . However, when you’re dealing with an inaccessible alternative field such as bank loans, a steady guid...
In rating more than 1,200 equity ETFs, CFRA Research combines proprietary holdings-level analysis with fund attributes, such as its expense ratio and technical trends, notes CFRA Research analyst Todd Rosenbluth in The Outlook . The CFRA Focus ETF for July is iShares Edge MS...
In rating more than 1,200 equity ETFs, CFRA Research combines proprietary holdings-level analysis with fund attributes, such as its expense ratio and technical trends, notes CFRA Research analyst Todd Rosenbluth in The Outlook . The CFRA Focus ETF for July is iShares Edge MS...
Central banks are fueling the bull market as expectations mount for looser policy, writes Bill Baruch. E-mini S&P (ESU) Yesterday’s close: Settled at 3021.50, up 13.50 Fundamentals: The path of least resistance is higher, this is undeniable. The U.S economic data is ...
Our model portfolio closed out the month of June above $550K, meaning the 2 for 1 portfolio has grown 1000% since its inception 23 years ago; that’s an 11% annualized return, explains Neil Macneale , editor of 2-for-1 Stock Split Newsletter . Our long-standing practice ...
In a major coup for Ziopharm Oncology ( ZIOP ), the company has attracted the services of Drew Deniger, Ph.D., from the National Cancer Institute (NCI) to lead the company’s program to genetically modify T-cells to express neoantigen-specific T-cell receptors (TCRs), effective Ju...
Housing stocks have been a hit and miss affair all year, but there are two companies which should benefit from the current economic climate as long as bond yields and mortgage rates don’t start a nasty rising cycle and the job market doesn’t collapse, explains Joe Duarte , ...
Our macro themes are intended to focus your attention on the global macro trends that matter most, writes Landon Whaley , who breaks down his approach and performance. Capturing economic and financial market data and contextualizing it is something the Old Institution and its followers f...
Adrian Day , editor of Global Analyst , selected Gladstone Investment ( GAIN ) as his more conservative investment idea for 2019. The stock rose 21% in the first half. Here's his latest update on this specialized financial firm. Gladstone Investment is a Business Developmen...
Tim Plaehn , income specialist and editor of The Dividend Hunter , chose Starwood Property Trust ( STWD ) as his top conservative investment idea for 2019. The stock rose 15.2%% in the first half of the year. Here's his latest update on this commercial property REIT. For th...
News, Short Squeeze, Breakout and More Instantly...
Trending Stock
15.84%Change Percent:
Lexicon Pharmaceuticals Inc. Company Name:
LXRX Stock Symbol:
NASDAQ Market:
lexpharma.com Website: